Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Etrolizumab [USAN:INN]
RN: 1044758-60-2
UNII: I2A72G2V3J

Note

  • Selectively blocks lymphocyte homing to the gastrointestinal tract without affecting lymphocyte trafficking to non-mucosal tissues.

Molecular Formula

  • C6396-H9874-N1702-O2010-S42
 

Classification Code

  • Treatment of Inflammatory Bowel Disease (IBD)
* denotes mobile formatted website

Links to Resources

Names and Synonyms

Name of Substance

  • Etrolizumab [USAN:INN]

Synonyms

  • Anti-beta7
  • Etrolizumab
  • PRO145223
  • rhuMAb Beta7
  • UNII-I2A72G2V3J

Systematic Name

  • Immunoglobulin G1, anti-(human integrin alpha47/integrin alphaE7) (human-rat monoclonal rhuMAb Beta7 heavy chain), disulfide with human-rat monoclonal rhuMAb Beta7 light chain, dimer

Registry Numbers

CAS Registry Number

  • 1044758-60-2

FDA UNII

  • I2A72G2V3J

System Generated Number

  • 1044758602